Simvastatin is associated with superior lipid and glycaemic control to atorvastatin and reduced levels of incident Type 2 diabetes, in men and women, in the UK Biobank

INTRODUCTION: Cardiovascular disease (CVD) is the leading cause of mortality in people with Type 2 diabetes mellitus (T2DM). Statins reduce low‐density lipoproteins and positively affect CVD outcomes. Statin type and dose have differential effects on glycaemia and risk of incident T2DM; however, the...

Descripción completa

Detalles Bibliográficos
Autores principales: English, Andrew R., Prasad, Bodhayan, McGuigan, Declan H., Horigan, Geraldine, O’Kane, Maurice, Bjourson, Anthony J., Shukla, Priyank, Kelly, Catriona, McClean, Paula L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094470/
https://www.ncbi.nlm.nih.gov/pubmed/35243827
http://dx.doi.org/10.1002/edm2.326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094470/
https://www.ncbi.nlm.nih.gov/pubmed/35243827
http://dx.doi.org/10.1002/edm2.326

Ejemplares similares